Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Leidos Schedules Third Quarter 2016 Earnings Conference Call for November 3, 2016 at 8AM ET

BIOCORP
Posted on: 30 Sep 16

RESTON, Va., Sept. 29, 2016 /PRNewswire/ -- Leidos Holdings, Inc. (Leidos) (NYSE: LDOS), a national security, health and infrastructure solutions company, has scheduled a conference call for Thursday, November 3, 2016, at 8:00 AM ET to announce its third quarter 2016 financial results for the period ending Friday, September 30, 2016.  The company plans to issue its quarterly earnings press release before the conference call on November 3, 2016.

Date:               November 3, 2016

Time:              8:00 AM (ET)

To Listen via the Internet:   

We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at http://ir.leidos.com.

To Listen via Telephone:

877-869-3847 (toll-free U.S.)

+1-201-689-8261 (for International Callers)

Replay:          

A telephone playback of the third quarter 2016 earnings conference call is scheduled to be available beginning at 11:00 AM (ET) on November 3, 2016, through 11:59 PM (ET) on November 10, 2016.  The replay will be accessible by calling 877-660-6853 (International callers: 201-612-7415), and entering conference ID 13646428. 

An archived version of the webcast will be available on the Leidos Investor Relations website at http://ir.leidos.com.

About Leidos

Leidos is a global science and technology solutions leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended Jan. 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit www.Leidos.com.

Media contact:
Melissa Koskovich
571.526.6850
koskovichm@leidos.com

Investor Relations:
Kelly P. Hernandez
571.526.6404
kelly.p.hernandez@leidos.com

For more information:
www.prnewswire.com/news-releases/leidos-schedules-third-quarter-2016-earnings-conference-call-for-november-3-2016-at-8am-et-300336394.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.